Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Amyloid age and tau PET timeline to symptomatic Alzheimer’s disease in Down syndrome

Emily K. Schworer, Matthew D. Zammit, Jiebiao Wang, Benjamin L. Handen, Tobey Betthauser, Charles M. Laymon, Dana L. Tudorascu, Annie D. Cohen, Shahid H. Zaman, Beau M. Ances, Mark Mapstone, Elizabeth Head, William E. Klunk, Bradley T. Christian, Sigan L. Hartley, Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS)
doi: https://doi.org/10.1101/2024.08.08.24311702
Emily K. Schworer
1University of Wisconsin-Madison Waisman Center,1500 Highland Ave, Madison, WI 53705, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew D. Zammit
1University of Wisconsin-Madison Waisman Center,1500 Highland Ave, Madison, WI 53705, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiebiao Wang
2University of Pittsburgh School of Public Health, 130 DeSoto Street, Pittsburgh, PA 15261, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin L. Handen
3University of Pittsburgh Department of Psychiatry, 3811 O’Hara St, Pittsburgh, PA 15213, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobey Betthauser
4University of Wisconsin-Madison Alzheimer’s Disease Research Center, 600 Highland Ave, Madison, WI 53792, USA
5University of Wisconsin-Madison Department of Medicine, 1685 Highland Ave, Madison, WI 53792, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles M. Laymon
6University of Pittsburgh Department of Radiology, 200 Lothrop Street, Pittsburgh, PA 15213, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana L. Tudorascu
3University of Pittsburgh Department of Psychiatry, 3811 O’Hara St, Pittsburgh, PA 15213, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie D. Cohen
3University of Pittsburgh Department of Psychiatry, 3811 O’Hara St, Pittsburgh, PA 15213, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahid H. Zaman
7Cambridge Intellectual Disability Research Group, University of Cambridge, 18b Trumpington road, Cambridge CB2 8AH, UK
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beau M. Ances
8Washington University in St. Louis Department of Neurology, 660 S. Euclid Ave, St. Louis, MO 63110, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Mapstone
9Department of Neurology, University of California, Irvine School of Medicine, Irvine, California, 92617, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Head
10Department of Pathology & Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, California, 92617, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William E. Klunk
3University of Pittsburgh Department of Psychiatry, 3811 O’Hara St, Pittsburgh, PA 15213, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley T. Christian
1University of Wisconsin-Madison Waisman Center,1500 Highland Ave, Madison, WI 53705, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigan L. Hartley
1University of Wisconsin-Madison Waisman Center,1500 Highland Ave, Madison, WI 53705, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: slhartley{at}wisc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data used in this study are available from the Alzheimer Biomarker Consortium- Down Syndrome data repository located in the University kf Southern California Image and Data Archive: https://ida.loni.usc.edu/login.jsp

https://ida.loni.usc.edu/login.jsp

Back to top
PreviousNext
Posted August 09, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Amyloid age and tau PET timeline to symptomatic Alzheimer’s disease in Down syndrome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Amyloid age and tau PET timeline to symptomatic Alzheimer’s disease in Down syndrome
Emily K. Schworer, Matthew D. Zammit, Jiebiao Wang, Benjamin L. Handen, Tobey Betthauser, Charles M. Laymon, Dana L. Tudorascu, Annie D. Cohen, Shahid H. Zaman, Beau M. Ances, Mark Mapstone, Elizabeth Head, William E. Klunk, Bradley T. Christian, Sigan L. Hartley, Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS)
medRxiv 2024.08.08.24311702; doi: https://doi.org/10.1101/2024.08.08.24311702
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Amyloid age and tau PET timeline to symptomatic Alzheimer’s disease in Down syndrome
Emily K. Schworer, Matthew D. Zammit, Jiebiao Wang, Benjamin L. Handen, Tobey Betthauser, Charles M. Laymon, Dana L. Tudorascu, Annie D. Cohen, Shahid H. Zaman, Beau M. Ances, Mark Mapstone, Elizabeth Head, William E. Klunk, Bradley T. Christian, Sigan L. Hartley, Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS)
medRxiv 2024.08.08.24311702; doi: https://doi.org/10.1101/2024.08.08.24311702

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)